167 related articles for article (PubMed ID: 31070037)
21. Utility of Endoscopic Ultrasound-Guided Biopsy for Next-Generation Sequencing of Pancreatic Exocrine Malignancies.
Larson BK; Tuli R; Jamil LH; Lo SK; Deng N; Hendifar AE
Pancreas; 2018 Sep; 47(8):990-995. PubMed ID: 30028448
[TBL] [Abstract][Full Text] [Related]
22. Prospective validation of microRNA signatures for detecting pancreatic malignant transformation in endoscopic-ultrasound guided fine-needle aspiration biopsies.
Frampton AE; Krell J; Prado MM; Gall TM; Abbassi-Ghadi N; Del Vecchio Blanco G; Funel N; Giovannetti E; Castellano L; Basyouny M; Habib NA; Kaltsidis H; Vlavianos P; Stebbing J; Jiao LR
Oncotarget; 2016 May; 7(19):28556-69. PubMed ID: 27086919
[TBL] [Abstract][Full Text] [Related]
23. A Comparative Study of the Diagnostic Utility of Endoscopic Ultrasound-Guided Fine Needle Aspiration Cytology (EUS-FNA) versus Endoscopic Ultrasound-Guided Fine Needle Biopsy (EUS-FNB) in Pancreatic and Non-Pancreatic Lesions.
Yousri M; Abusinna E; Tahoun N; Okasha HH; El-Habashi AH
Asian Pac J Cancer Prev; 2022 Jun; 23(6):2151-2158. PubMed ID: 35763660
[TBL] [Abstract][Full Text] [Related]
24. Endoscopic ultrasound-guided tissue acquisition for pancreatic ductal adenocarcinoma in the era of precision medicine.
Ashida R; Kitano M
Dig Endosc; 2022 Nov; 34(7):1329-1339. PubMed ID: 35488448
[TBL] [Abstract][Full Text] [Related]
25. Targeted Transcriptome and
Lundy J; Gao H; Berry W; Masoumi-Moghoddam S; Jenkins BJ; Croagh D
Clin Cancer Res; 2021 Nov; 27(21):5900-5911. PubMed ID: 34400416
[TBL] [Abstract][Full Text] [Related]
26. Pretherapeutic evaluation of patients with upper gastrointestinal tract cancer using endoscopic and laparoscopic ultrasonography.
Mortensen MB
Dan Med J; 2012 Dec; 59(12):B4568. PubMed ID: 23290296
[TBL] [Abstract][Full Text] [Related]
27. Clinical Impact of KRAS and GNAS Analysis Added to CEA and Cytology in Pancreatic Cystic Fluid Obtained by EUS-FNA.
Faias S; Duarte M; Albuquerque C; da Silva JP; Fonseca R; Roque R; Dias Pereira A; Chaves P; Cravo M
Dig Dis Sci; 2018 Sep; 63(9):2351-2361. PubMed ID: 29796909
[TBL] [Abstract][Full Text] [Related]
28. Evaluation and diagnostic value of next-generation sequencing analysis of residual liquid-based cytology specimens of pancreatic masses.
Sekita-Hatakeyama Y; Fujii T; Nishikawa T; Mitoro A; Sawai M; Itami H; Morita K; Uchiyama T; Takeda M; Sho M; Yoshiji H; Hatakeyama K; Ohbayashi C
Cancer Cytopathol; 2022 Mar; 130(3):202-214. PubMed ID: 34665935
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of EUS-guided FNB using a Franseen needle for tissue acquisition and microsatellite instability evaluation in unresectable pancreatic lesions.
Sugimoto M; Irie H; Takagi T; Suzuki R; Konno N; Asama H; Sato Y; Nakamura J; Takasumi M; Hashimoto M; Kato T; Kobashi R; Kobayashi Y; Hashimoto Y; Hikichi T; Ohira H
BMC Cancer; 2020 Nov; 20(1):1094. PubMed ID: 33176750
[TBL] [Abstract][Full Text] [Related]
30. Endoscopic ultrasound may be used to deliver gene expression signatures using digital mRNA detection methods to immunophenotype pancreatic ductal adenocarcinoma to facilitate personalized immunotherapy.
Gleeson FC; Levy MJ; Jackson RA; Murphy SJ; Halling KC; Kipp BR; Graham RP; Zhang L
Pancreatology; 2020 Mar; 20(2):229-238. PubMed ID: 31831392
[TBL] [Abstract][Full Text] [Related]
31. Touch imprint cytology on endoscopic ultrasound fine-needle biopsy provides comparable sample quality and diagnostic yield to standard endoscopic ultrasound fine-needle aspiration specimens in the evaluation of solid pancreatic lesions.
Crinò SF; Larghi A; Bernardoni L; Parisi A; Frulloni L; Gabbrielli A; Parcesepe P; Scarpa A; Manfrin E
Cytopathology; 2019 Mar; 30(2):179-186. PubMed ID: 30484917
[TBL] [Abstract][Full Text] [Related]
32. Targeted next-generation sequencing of EUS-guided through-the-needle-biopsy sampling from pancreatic cystic lesions.
Rift CV; Melchior LC; Kovacevic B; Klausen P; Toxværd A; Grossjohann H; Karstensen JG; Brink L; Hassan H; Kalaitzakis E; Storkholm J; Scheie D; Hansen CP; Lund EL; Vilmann P; Hasselby JP
Gastrointest Endosc; 2023 Jan; 97(1):50-58.e4. PubMed ID: 35964683
[TBL] [Abstract][Full Text] [Related]
33. Routine Molecular Profiling in Both Resectable and Unresectable Pancreatic Adenocarcinoma: Relevance of Cytologic Samples.
Redegalli M; Grassini G; Magliacane G; Pecciarini L; Schiavo Lena M; Smart CE; Johnston RL; Waddell N; Maestro R; Macchini M; Orsi G; Petrone MC; Rossi G; Balzano G; Falconi M; Arcidiacono PG; Reni M; Doglioni C; Cangi MG
Clin Gastroenterol Hepatol; 2023 Oct; 21(11):2825-2833. PubMed ID: 36280101
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic Evaluation of Solid Pancreatic Lesions: Endoscopic Ultrasound-Guided Fine Needle Aspiration Versus Percutaneous Ultrasound-Guided Core Needle Biopsy.
Caymaz I; Afandiyeva N
Cardiovasc Intervent Radiol; 2023 Nov; 46(11):1596-1602. PubMed ID: 37464106
[TBL] [Abstract][Full Text] [Related]
35. Next-generation sequencing-based multi-gene mutation profiling of solid tumors using fine needle aspiration samples: promises and challenges for routine clinical diagnostics.
Kanagal-Shamanna R; Portier BP; Singh RR; Routbort MJ; Aldape KD; Handal BA; Rahimi H; Reddy NG; Barkoh BA; Mishra BM; Paladugu AV; Manekia JH; Kalhor N; Chowdhuri SR; Staerkel GA; Medeiros LJ; Luthra R; Patel KP
Mod Pathol; 2014 Feb; 27(2):314-27. PubMed ID: 23907151
[TBL] [Abstract][Full Text] [Related]
36. KRAS mutation testing on all non-malignant diagnosis of pancreatic endoscopic ultrasound-guided fine-needle aspiration biopsies improves diagnostic accuracy.
Trisolini E; Armellini E; Paganotti A; Veggiani C; Bozzola C; Frattini M; Pizio C; Mancuso G; Andorno S; Boldorini R
Pathology; 2017 Jun; 49(4):379-386. PubMed ID: 28450086
[TBL] [Abstract][Full Text] [Related]
37. Next-generation sequencing of endoscopically obtained tissues from patients with all stages of pancreatic cancer.
Takano S; Fukasawa M; Shindo H; Takahashi E; Fukasawa Y; Kawakami S; Hayakawa H; Kuratomi N; Kadokura M; Yamaguchi T; Inoue T; Maekawa S; Enomoto N
Cancer Sci; 2022 Mar; 113(3):1069-1077. PubMed ID: 34962016
[TBL] [Abstract][Full Text] [Related]
38. Gene expression profiling of morphologic subtypes of pancreatic ductal adenocarcinoma using surgical and EUS-FNB specimens.
Rasmussen LG; Verbeke CS; Sørensen MD; Pfeiffer P; Tan Q; Mortensen MB; Fristrup C; Detlefsen S
Pancreatology; 2021 Apr; 21(3):530-543. PubMed ID: 33637450
[TBL] [Abstract][Full Text] [Related]
39. Combination of KRAS and SMAD4 mutations in formalin-fixed paraffin-embedded tissues as a biomarker for pancreatic cancer.
Yokose T; Kitago M; Matsuda S; Sasaki Y; Masugi Y; Nakamura Y; Shinoda M; Yagi H; Abe Y; Oshima G; Hori S; Yusuke F; Nakano Y; Endo Y; Abe K; Tokino T; Kitagawa Y
Cancer Sci; 2020 Jun; 111(6):2174-2182. PubMed ID: 32314446
[TBL] [Abstract][Full Text] [Related]
40. Comparison of endoscopic ultrasound-guided fine-needle biopsy versus fine-needle aspiration for genomic profiling and DNA yield in pancreatic cancer: a randomized crossover trial.
Kandel P; Nassar A; Gomez V; Raimondo M; Woodward TA; Crook JE; Fares NS; Wallace MB
Endoscopy; 2021 Apr; 53(4):376-382. PubMed ID: 32767288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
